The AACR-Debbie’s Dream Foundation Gastric Cancer Innovation and Discovery Grant is a grant mechanism that seeks to encourage innovation and translation of ideas from basic research into new treatment options for gastric cancer. Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research.
This Grant provides $100,000 over two years for expenses related to the research project. Grant funds may be used for direct and indirect research expenses attributable to the project, which may include supplemental salary support, equipment, research/laboratory supplies, and other research expenses.
Research Project Criteria
These grants will support basic, translational, and/or clinical research projects that examine important and druggable* novel targets and/or biomarkers that are relevant for gastric cancer.
*For the purposes of this grant program, a "druggable" target is defined as a nucleic acid or a protein (e.g., an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small- molecular weight chemical compound or a biological, such as an antibody or a recombinant protein. The target should have been shown to be effective/mechanistically involved in cancer by relevant in vitro or in vivo models. A cancer-related biomarker might be a protein, a nucleic acid, or a metabolite that can be measured in biological fluids, tissue, or isolated cells for the diagnosis, monitoring, prognosis, or stratification of patients.
Grant Amount$100,000 USD
Grant Term2 Years
Start of Grant TermNovember 1, 2026
Application DeadlineJuly 22, 2026 1:00 PM
Decision DateOctober 2026
Additional InformationAdditional details regarding this grant can be found in the Program Guidelines and Application Instructions. Final determinations of eligibility will not be completed until the AACR is in receipt of the submitted application.
For Debbie’s Dream Foundation: Curing Stomach Cancer (DDF), the strongest grant success predictors are highly focused on advancing gastric (stomach) cancer research, particularly innovative projects that can improve diagnosis, treatment, biomarkers, and patient outcomes. Since 2014, DDF has invested more than $2 million in gastric cancer research grants, often in partnership with the American Association for Cancer Research. . states that its goal is to increase treatment options and survival for stomach cancer patients. grants. clinician-scientists or basic scientists arker studies, and translational immunology research. arker development and precision-medicine approaches for gastric cancer. particularly attractive to reviewers.
At the start of the grant term (November 1, 2026), applicants must:
At the start of the grant term (November 1, 2026), applicants cannot:
All applicants with questions about eligibility should contact the AACR’s Research and Grants Administration at grants@aacr.org before submitting an application.
Sponsor Institute/Organizations: Debbie’s Dream Foundation
Sponsor Type: Corporate/Non-Profit
Address: 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jul 22, 2026
Jul 22, 2026
$100,000
Affiliation: Debbie’s Dream Foundation
Address: 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404
Website URL: https://www.aacr.org/grants/aacr-debbies-dream-foundation-innovation-and-discovery-grant/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.